Associate/Full Professor — Radiopharmaceutical Sciences / Radioligand Therapy (Tenure-Track) - MITC

Hiring Department

University of Missouri-Columbia
College of Arts and Science
Department of Chemistry
Assistant Professor - Molecular Imaging and Theranostics Center (MITC) Radiopharmaceutical Sciences

Job Description

We are also recruiting two other roles for the MITC. These positions can be found by searching the job title or job ID number below:

• Assistant Professor – MITC (job ID 61193)
• Research Scientist – MITC (job ID 61198)

The University of Missouri (MU) seeks applications and nominations for three coordinated positions in radiopharmaceutical sciences, broadly defined: an Assistant Professor, an Associate/Full Professor (both tenure-track), and a Senior Research Scientist (non-tenure-track). Multiple appointments in each track are possible. These appointments are part of MizzouForward , the most important strategic investment to achieve research excellence and student success in the history of the university. This initiative will leverage existing institutional strengths and address national health and scientific priority areas through innovation and collaboration. Successful candidates will have outstanding, competitive, externally funded research programs in any area of radiopharmaceutical sciences including, but not limited to, imaging, theranostics, radiobiology, and dosimetry. Positions are available in the Departments Chemistry and Physics in the College of Arts & Science, Departments of Chemical and Biomedical Engineering in the College of Engineering and the Department of Biochemistry in the School of Medicine. Appointments and / or joint appointments in other departments are possible.

A centerpiece of the University’s focus on radiopharmaceutical excellence is the University of Missouri research reactor ( MURR ) – the most powerful on a university campus in North America. MURR produces several medically important isotopes such as Lu-177 and Tb-161. Recently, the University has built a world-class preclinical radiopharmaceutical development center: the Molecular Imaging and Theranostics Center (MITC). MITC hosts a full suite of radiochemistry and pre-clinical imaging capabilities. MITC partners with the NextGen Precision Health Initiative . Established in 2021, the NextGen Precision Health Institute (NGPHI) provides research faculty from across the University of Missouri System with a new cutting-edge research facility dedicated to solving our most pressing health concerns.

Associate/Full Professor — Radiopharmaceutical Sciences / Radioligand Therapy (Tenure-Track)

The Associate/Full Professor will anchor the cluster as an established, externally funded investigator able to lead on arrival, directing preclinical discovery research in MITC. The appointee will use MITC’s radiochemistry laboratories, radioactive vivarium, small-animal PET, SPECT/CT, and MRI, and dedicated alpha laboratories (Pb-212, At-211, Ac-225), together with reactor-produced Lu-177, Tb-161, and other beta-emitting isotopes from MURR next door. The role includes mentoring the cluster’s junior faculty hires and connecting MURR isotope production, large-animal studies conducted with the College of Veterinary Medicine, and the phase 1 radiopharmaceutical clinical trials program in the School of Medicine. The appointee will carry graduate instructional responsibilities in radiochemistry and radiopharmaceutical sciences and will be expected to chair doctoral committees.

Qualifications

Minimum Qualification

• An earned terminal degree in a related discipline

Candidates will be evaluated on the following factors

• Track record of external research funding, particularly from federal agencies
• Research portfolio and accomplishments (e.g., publication record, number of citations)